Australia's 'Green Whistle' Company Closes $76-Million European Deal
Australia's 'Green Whistle' Company Closes $76-Million European
Deal
Medical Developments International, the
Australian company behind the "green whistle" pain relief inhaler,
finalized an European licensing deal. The deal allows Mundipharma International
Corporation to license, develop, and commercialize Penthrox, a self-inhaled
analgesic for the treatment of emergency pain in several European markets.
Mundipharma will have exclusive product rights to Penthrox in 39 European markets,
including France, Germany, Italy, and Spain. It excludes Hungary, the Republic
of Ireland, and the United Kingdom. Under the terms of the agreement,
Mundipharma will pay Medical Developments upfront and milestone payments of up
to $54.5 million, including $7 million upon signing.
From "Australia's 'Green Whistle'
Company Has Closed a $76 Million Deal in Europe". Business Insider
Australia (09/14/15) Pash, Chris
Link: Australia's 'Green Whistle' Company Closes
$76-Million European Deal